Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia

Citations Over TimeTop 10% of 2012 papers

Abstract

Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6-7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)-initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized.

Related Papers

• → Transitional dynamics in oncology clinical trials: evaluating the impact of Clinical Trials Act on cooperative groups(2024)3 cited
• → Evaluation of knowledge and attitudes of the faculty of medicine students about human papillomavirus infections, related cancers, and human papillomavirus vaccines(2023)2 cited
• → Trends of clinical trials from 2014 to 2016 in South Korea(2018)3 cited
• → A Watershed Role of the Central Office of Investigator-initiated Clinical Trial in Cardiovascular Fields(2013)
• Latest PARSPORT Results Confirm: IMRT Greatly Reduces Treatment Effects in Head and Neck Cancer(2011)